$2.05
-0.12-5.53%
At close: -
$2.08
0.031.42%
After Hours: Jan 17, 7:46 PM EDT
Comments
Loading...
Neumora Therapeutics (NMRA) Forecast
NewsEarningsNeumora Therapeutics (NMRA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestNeumora Therapeutics (NASDAQ:NMRA) Stock Quotes, Forecast and News Summary
Neumora Therapeutics Stock (NASDAQ: NMRA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Neumora Therapeutics (NMRA) stock?
You can purchase shares of Neumora Therapeutics (NASDAQ:NMRA) through any online brokerage.
Who are Neumora Therapeutics (NMRA) competitors?
Other companies in Neumora Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD) and GH Research (NASDAQ:GHRS).
What is the forecast, or price target, for Neumora Therapeutics (NMRA) stock?
Neumora Therapeutics has a consensus price target of $21.50.
What is the current price for Neumora Therapeutics (NMRA)?
The stock price for Neumora Therapeutics (NASDAQ: NMRA) is $2.0791 last updated January 17, 2025 at 7:46 PM EST.
Does Neumora Therapeutics (NMRA) pay a dividend?
There are no upcoming dividends for Neumora Therapeutics.
When is Neumora Therapeutics (NASDAQ:NMRA) reporting earnings?
Neumora Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.
Is Neumora Therapeutics (NMRA) going to split?
There is no upcoming split for Neumora Therapeutics.
What sector and industry does Neumora Therapeutics (NMRA) operate in?
Neumora Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.